Reuters logo
BRIEF-Cumberland Pharmaceuticals Q2 adjusted loss per share $0.05
2017年8月8日 / 晚上8点17分 / 2 个月前

BRIEF-Cumberland Pharmaceuticals Q2 adjusted loss per share $0.05

Aug 8 (Reuters) - Cumberland Pharmaceuticals Inc

* Cumberland Pharmaceutical reports double digit revenue growth for the fourth consecutive quarter

* Q2 adjusted loss per share $0.05

* Q2 loss per share $0.32

* Q2 revenue rose 17 percent to $8.7 million

* Cumberland Pharmaceuticals - ‍new co-promotion agreement for Kristalose added; at June 30, had $49.0 million in cash and marketable securities, including approximately $34.6 million in cash and equivalents​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below